chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lacrimation increased, Nausea, Rhinorrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (Watery eye), RHINORRHOEA (Runny Nose), HEADACHE (Headache) and NAUSEA (Nausea) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure, Diabetes, Cholesterol and Heart disorder.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced LACRIMATION INCREASED (Watery eye), RHINORRHOEA (Runny Nose), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, LACRIMATION INCREASED (Watery eye), RHINORRHOEA (Runny Nose), HEADACHE (Headache) and NAUSEA (Nausea) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products include Blood pressure medicine, Heart medicine, Diabetes medicine and Cholesterol medicine. No Treatment information reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Significant FU received contains outcome of the events as not recovered not resolved.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site pruritus
Clinical narrative: Skin around the injection site have turned red; Looks raised bump similar to mosquito bite; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Skin around the injection site have turned red), INJECTION SITE MASS (Looks raised bump similar to mosquito bite) and INJECTION SITE PRURITUS (Itchy) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Skin around the injection site have turned red), INJECTION SITE MASS (Looks raised bump similar to mosquito bite) and INJECTION SITE PRURITUS (Itchy). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE ERYTHEMA (Skin around the injection site have turned red), INJECTION SITE MASS (Looks raised bump similar to mosquito bite) and INJECTION SITE PRURITUS (Itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: itchy at the injection site; rash at the injection site; red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE PRURITUS (itchy at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's medical history was not reported.  Concomitant products included EZETIMIBE (ZETIA), ZINC, VITAMIN D NOS and CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (rash at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE PRURITUS (itchy at the injection site). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL, PHENYLPROPANOLAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE;PARACETAMOL;PHENYLPROPANOLAMINE HYDROCHLORIDE]) (topical) in January 2021 for Adverse event, at a dose of UNK dosage form. On 03-Feb-2021, VACCINATION SITE PRURITUS (itchy at the injection site) had resolved. At the time of the report, VACCINATION SITE RASH (rash at the injection site) and VACCINATION SITE ERYTHEMA (red at the injection site) was resolving.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication included natures "bounty hair skin and nails". The patient got the rash at the injection site 1 week after vaccination. Itching went away after 2 weeks. It was reported that Benadryl cream helped.   This case was linked to MOD-2021-033065 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Nausea
Clinical narrative: pregnant; nausea; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) and NAUSEA (nausea) in a 41-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 23-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant) and NAUSEA (nausea). On 23-Mar-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved. At the time of the report, NAUSEA (nausea) outcome was unknown.            No concomitant medication was provided. No treatment information was reported.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Night sweats
Clinical narrative: night sweats; body ache; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (night sweats) and MYALGIA (body ache) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BIOTIN;MINERALS NOS;NICOTINIC ACID;RETINOL;TOCOPHEROL;VITAMIN B NOS;VITAMIN D NOS] for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced NIGHT SWEATS (night sweats) and MYALGIA (body ache). At the time of the report, NIGHT SWEATS (night sweats) had resolved and MYALGIA (body ache) outcome was unknown. Not Provided          No treatment information was reported. Patient experienced night sweats after both the doses which lasted a day and felt fine later.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Significant FU - 2nd dose information added and event night sweats outcome updated
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Lip pruritus, Peripheral swelling
Clinical narrative: bottom lip on left side got kind of big, started itching; left hand can barely open and close; little finger on right hand got swollen; This spontaneous case was reported by a patient and describes the occurrence of LIP PRURITUS (bottom lip on left side got kind of big, started itching), HYPOKINESIA (left hand can barely open and close) and PERIPHERAL SWELLING (little finger on right hand got swollen) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Bronchitis.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Feb-2021, the patient experienced LIP PRURITUS (bottom lip on left side got kind of big, started itching), HYPOKINESIA (left hand can barely open and close) and PERIPHERAL SWELLING (little finger on right hand got swollen). At the time of the report, LIP PRURITUS (bottom lip on left side got kind of big, started itching), HYPOKINESIA (left hand can barely open and close) and PERIPHERAL SWELLING (little finger on right hand got swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for COVID; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Tested positive for COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for COVID). At the time of the report, COVID-19 (Tested positive for COVID) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant product use was reported No treatment information was reported
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Tenderness
Clinical narrative: tenderness in right arm; Itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and TENDERNESS (tenderness in right arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. P5M2P0A and P25A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PRURITUS (Itching). On an unknown date, the patient experienced TENDERNESS (tenderness in right arm). At the time of the report, PRURITUS (Itching) and TENDERNESS (tenderness in right arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-056601 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056601:CROSS LINKED for Dose 2
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant female received vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant female received vaccine) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 15-Sep-2020 and the estimated date of delivery was 09-Jul-2021. On 02-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant female received vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy.  On 02-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant female received vaccine) had resolved.            Treatment drugs were not provided concomitant drugs were not provided.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: headache; nausea; body aches; fever of 104; chills that have continued and not going away; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (nausea), MYALGIA (body aches), PYREXIA (fever of 104) and CHILLS (chills that have continued and not going away) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), NAUSEA (nausea), MYALGIA (body aches), PYREXIA (fever of 104) and CHILLS (chills that have continued and not going away). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEADACHE (headache), NAUSEA (nausea), MYALGIA (body aches), PYREXIA (fever of 104) and CHILLS (chills that have continued and not going away) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable No concomitant medication were reported
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Worse Itching; itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Worse Itching) and PRURITUS (itching) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. P5M2P0A) for COVID-19 vaccination.    Co-suspect product included mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. P25A21A) for COVID-19 vaccination.    The patient's past medical history included No adverse event.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 25-Feb-2021, the patient experienced PRURITUS (itching). On 11-Mar-2021, the patient experienced PRURITUS (Worse Itching). At the time of the report, PRURITUS (itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-056587 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056587:CROSS LINKED for Dose 1
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Hypoaesthesia, Paraesthesia
Clinical narrative: feeling numb around the bottom of her face; a little tingling; a little flush around her face; This spontaneous case was reported by a patient and describes the occurrence of HYPOAESTHESIA (feeling numb around the bottom of her face), PARAESTHESIA (a little tingling) and FLUSHING (a little flush around her face) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 27-Feb-2021, the patient experienced HYPOAESTHESIA (feeling numb around the bottom of her face), PARAESTHESIA (a little tingling) and FLUSHING (a little flush around her face). On 27-Feb-2021, HYPOAESTHESIA (feeling numb around the bottom of her face), PARAESTHESIA (a little tingling) and FLUSHING (a little flush around her face) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness). At the time of the report, VACCINATION SITE PAIN (soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Concomitant product use was not provided by the reporter.  No treatment was reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Joint swelling
Clinical narrative: Swollen hand and wrist in left side after second dose; Nose bleeds; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Swollen hand and wrist in left side after second dose) and EPISTAXIS (Nose bleeds) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (Swollen hand and wrist in left side after second dose) and EPISTAXIS (Nose bleeds). At the time of the report, JOINT SWELLING (Swollen hand and wrist in left side after second dose) and EPISTAXIS (Nose bleeds) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-042884 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up received on 11-MAY-2021 , Patient detail received; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-042884:first dose
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included AIDS and Blood pressure high.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced DIZZINESS (Dizzy). At the time of the report, DIZZINESS (Dizzy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was born on 1953. Concomitant medications taken by the patient included high blood pressure medications. Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow-up information received captured event outcome.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: arm pain at site of injection; This spontaneous case was reported by a non-health professional and describes the occurrence of INJECTION SITE PAIN (arm pain at site of injection) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced INJECTION SITE PAIN (arm pain at site of injection). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (arm pain at site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       concomitant medication information not provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Late 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Late 2nd dose) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Late 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Late 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was reported.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle tightness
Clinical narrative: tightening upper back muscles/tightening upper arm muscles; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (tightening upper back muscles/tightening upper arm muscles) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included Ecitalopram for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced MUSCLE TIGHTNESS (tightening upper back muscles/tightening upper arm muscles). At the time of the report, MUSCLE TIGHTNESS (tightening upper back muscles/tightening upper arm muscles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Pain in injected left arm at shoulder/Pain in right arm at shoulder; Pain in muscle in arm of injection/Pain in right shoulder muscle; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in injected left arm at shoulder/Pain in right arm at shoulder) and MYALGIA (Pain in muscle in arm of injection/Pain in right shoulder muscle) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS, Acid reflux (oesophageal), Hyperlipidemia and Depression.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced ARTHRALGIA (Pain in injected left arm at shoulder/Pain in right arm at shoulder) and MYALGIA (Pain in muscle in arm of injection/Pain in right shoulder muscle). At the time of the report, ARTHRALGIA (Pain in injected left arm at shoulder/Pain in right arm at shoulder) and MYALGIA (Pain in muscle in arm of injection/Pain in right shoulder muscle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications included thyroid medication, acid reflux medication, antihyperlipidemic medication and antidepressant medication (not specified). The patient did not take any treatment medication..   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-MAY-2021: Contain Non significant follow up
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: body aches; chills; headache; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN (body aches), CHILLS (chills) and HEADACHE (headache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026a21a) for COVID-19 vaccination.     Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN (body aches), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN (body aches), CHILLS (chills) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Nausea, Vaccination site erythema
Clinical narrative: Warm near the injection site; Fatigue; Nausea; Muscle pain; Joint pain; Redness on the right arm; Puffy arm near injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm near the injection site), FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE BESYLATE and VALSARTAN for an unknown indication.    On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm near the injection site), FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), VACCINATION SITE ERYTHEMA (Redness on the right arm) and VACCINATION SITE SWELLING (Puffy arm near injection site). At the time of the report, VACCINATION SITE WARMTH (Warm near the injection site), FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), VACCINATION SITE ERYTHEMA (Redness on the right arm) and VACCINATION SITE SWELLING (Puffy arm near injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warm near the injection site; Fatigue; Nausea; Muscle pain; Joint pain; Redness on the right arm; Puffy arm near injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm near the injection site), FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE BESYLATE and VALSARTAN for an unknown indication.    On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm near the injection site), FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), VACCINATION SITE ERYTHEMA (Redness on the right arm) and VACCINATION SITE SWELLING (Puffy arm near injection site). At the time of the report, VACCINATION SITE WARMTH (Warm near the injection site), FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), VACCINATION SITE ERYTHEMA (Redness on the right arm) and VACCINATION SITE SWELLING (Puffy arm near injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dysphagia, Fatigue, Feeling abnormal, Pain
Clinical narrative: tired; achy; doesn't feel like herself; upper lip tingling; prickling in her throat and tonsil area; hard time swallowing; shooting chest pain, around heart; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (upper lip tingling), PHARYNGEAL PARAESTHESIA (prickling in her throat and tonsil area), DYSPHAGIA (hard time swallowing), CHEST PAIN (shooting chest pain, around heart) and FATIGUE (tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PARAESTHESIA ORAL (upper lip tingling), PHARYNGEAL PARAESTHESIA (prickling in her throat and tonsil area), DYSPHAGIA (hard time swallowing) and CHEST PAIN (shooting chest pain, around heart). On 18-Mar-2021, the patient experienced FATIGUE (tired), PAIN (achy) and FEELING ABNORMAL (doesn't feel like herself). On 17-Mar-2021, PARAESTHESIA ORAL (upper lip tingling), PHARYNGEAL PARAESTHESIA (prickling in her throat and tonsil area), DYSPHAGIA (hard time swallowing) and CHEST PAIN (shooting chest pain, around heart) had resolved. At the time of the report, FATIGUE (tired), PAIN (achy) and FEELING ABNORMAL (doesn't feel like herself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Pharyngeal paraesthesia
Clinical narrative: tired; achy; doesn't feel like herself; upper lip tingling; prickling in her throat and tonsil area; hard time swallowing; shooting chest pain, around heart; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (upper lip tingling), PHARYNGEAL PARAESTHESIA (prickling in her throat and tonsil area), DYSPHAGIA (hard time swallowing), CHEST PAIN (shooting chest pain, around heart) and FATIGUE (tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PARAESTHESIA ORAL (upper lip tingling), PHARYNGEAL PARAESTHESIA (prickling in her throat and tonsil area), DYSPHAGIA (hard time swallowing) and CHEST PAIN (shooting chest pain, around heart). On 18-Mar-2021, the patient experienced FATIGUE (tired), PAIN (achy) and FEELING ABNORMAL (doesn't feel like herself). On 17-Mar-2021, PARAESTHESIA ORAL (upper lip tingling), PHARYNGEAL PARAESTHESIA (prickling in her throat and tonsil area), DYSPHAGIA (hard time swallowing) and CHEST PAIN (shooting chest pain, around heart) had resolved. At the time of the report, FATIGUE (tired), PAIN (achy) and FEELING ABNORMAL (doesn't feel like herself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain
Clinical narrative: Feel horrible; Hurts all over my body; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feel horrible) and PAIN (Hurts all over my body) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced FEELING ABNORMAL (Feel horrible) and PAIN (Hurts all over my body). At the time of the report, FEELING ABNORMAL (Feel horrible) and PAIN (Hurts all over my body) had not resolved. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided. No treatment information provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Dizziness, Nerve compression, Paraesthesia
Clinical narrative: felt lightheaded; Pinched nerve; Numbness on face; Tingling sensation on face; The left side of the face was burning; Left side of the arm was burning; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (felt lightheaded), NERVE COMPRESSION (Pinched nerve), PARAESTHESIA (Numbness on face), PARAESTHESIA (Tingling sensation on face) and BURNING SENSATION (The left side of the face was burning) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN (ADVIL 12 HOUR) and PARACETAMOL (TYLENOL) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced DIZZINESS (felt lightheaded), NERVE COMPRESSION (Pinched nerve), PARAESTHESIA (Numbness on face), PARAESTHESIA (Tingling sensation on face), BURNING SENSATION (The left side of the face was burning) and BURNING SENSATION (Left side of the arm was burning). At the time of the report, DIZZINESS (felt lightheaded), NERVE COMPRESSION (Pinched nerve), PARAESTHESIA (Numbness on face), PARAESTHESIA (Tingling sensation on face), BURNING SENSATION (The left side of the face was burning) and BURNING SENSATION (Left side of the arm was burning) had resolved.            Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not Applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up was received included AE outcome reported: Events have resolved
Sex: U
Vaccine: COVID19
Symptoms: Influenza like illness, Pain
Clinical narrative: Soreness; Flu-like Symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) and INFLUENZA LIKE ILLNESS (Flu-like Symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness) and INFLUENZA LIKE ILLNESS (Flu-like Symptoms). At the time of the report, PAIN (Soreness) and INFLUENZA LIKE ILLNESS (Flu-like Symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-056194, MOD-2021-056207, MOD-2021-056528, MOD-2021-056467, MOD-2021-056534 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Illness, Nausea, Pain of skin
Clinical narrative: Sickness; fever; nausea; vomiting; chills; joint pain; Skin pain; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in July 2020 and Thyroidectomy. Concomitant products included PANTOPRAZOLE and VITAMINS NOS for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced ILLNESS (Sickness), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), ARTHRALGIA (joint pain) and PAIN OF SKIN (Skin pain). On 10-Mar-2021, ILLNESS (Sickness), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), ARTHRALGIA (joint pain) and PAIN OF SKIN (Skin pain) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product also include Thyroid pill daily as patient's thyroid gland was removed.  No treatment information was reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-056389 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056389:Cross-linked cases
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Sickness; fever; nausea; vomiting; chills; joint pain; Skin pain; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in July 2020 and Thyroidectomy. Concomitant products included PANTOPRAZOLE and VITAMINS NOS for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced ILLNESS (Sickness), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), ARTHRALGIA (joint pain) and PAIN OF SKIN (Skin pain). On 10-Mar-2021, ILLNESS (Sickness), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), ARTHRALGIA (joint pain) and PAIN OF SKIN (Skin pain) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product also include Thyroid pill daily as patient's thyroid gland was removed.  No treatment information was reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-056389 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056389:Cross-linked cases
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Urinary tract infection
Clinical narrative: Possible UTI ( Test was Negative); Rash on the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Mar-2021 and was forwarded to Moderna on 24-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Possible UTI ( Test was Negative)) and INJECTION SITE RASH (Rash on the injection site) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 27-Feb-2021, the patient experienced INJECTION SITE RASH (Rash on the injection site). On 20-Mar-2021, the patient experienced URINARY TRACT INFECTION (Possible UTI ( Test was Negative)). At the time of the report, URINARY TRACT INFECTION (Possible UTI ( Test was Negative)) and INJECTION SITE RASH (Rash on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were Keflex Antibiotics .
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaginal haemorrhage
Clinical narrative: vaginal bleeding; knee pain; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (vaginal bleeding) and ARTHRALGIA (knee pain) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     Concurrent medical conditions included Vaginal bleeding.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VAGINAL HAEMORRHAGE (vaginal bleeding) and ARTHRALGIA (knee pain). At the time of the report, VAGINAL HAEMORRHAGE (vaginal bleeding) and ARTHRALGIA (knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Tremor
Clinical narrative: shaking; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking), CHILLS (chills) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (shaking), CHILLS (chills) and NAUSEA (nausea). At the time of the report, TREMOR (shaking), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Magnetic resonance imaging, Spinal X-ray, X-ray limb
Clinical narrative: Shingles; This spontaneous case was reported by a physician and describes the occurrence of HERPES ZOSTER (Shingles) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    The patient's past medical history included Knee replacement in 2014. Concurrent medical conditions included Knee pain since 2005, Psoriatic arthritis, Difficulty in walking, Joint range of motion decreased, Weakness since January 2019, Arthralgia since January 2019, Swelling of hands since January 2019, Joint swelling since January 2019, Back pain since January 2019, Hand pain since January 2019 and Spinal osteoarthritis since October 2019. Concomitant products included CLONAZEPAM (KLONOPIN) for Anxiety, LEVOTHYROXINE for Hypothyroidism and Supplementation therapy, GABAPENTIN for Nerve pain and Fibromyalgia, FOLIC ACID for Supplementation therapy, PROCAINE HYDROCHLORIDE (NOVOCAINE), PHENETICILLIN POTASSIUM (PENICILLIN B), AMOXICILLIN, CLINDAMYCIN and CEFALEXIN MONOHYDRATE (KEFLEX [CEFALEXIN MONOHYDRATE]) for an unknown indication.   In August 2019, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with CELECOXIB (CELEBREX) at an unspecified dose and frequency. On 05-Feb-2021, HERPES ZOSTER (Shingles) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2019, Magnetic resonance imaging: unknown (Inconclusive) DEGENERATION OF SPINE BONE. In October 2019, Spinal X-ray: unknown (Inconclusive) UNKNOWN. In October 2019, X-ray limb: unknown (Inconclusive) UNKNOWN.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered HERPES ZOSTER (Shingles) to be probably related.    Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: follow up received on 10-MAY-2021 and contains non significant information.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Rash
Clinical narrative: elevated temperature; rash all over; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE INCREASED (elevated temperature) and RASH (rash all over) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (elevated temperature) and RASH (rash all over). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 12-Mar-2021, BODY TEMPERATURE INCREASED (elevated temperature) and RASH (rash all over) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant product use was not provided.      Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Additional information received on 15-JUL-2021 and reporter information updated